Skip to main content

Table 1 Comparison of baseline anthropometric, laboratory and echocardiographic parameters of study participants

From: ACEF performed better than other risk scores in non-ST-elevation acute coronary syndrome during long term follow-up

Variables MACE Total (n = 276) P value
No (n = 212) Yes (n = 64)
Age (years) 63.2 ± 10.9 68.0 ± 11.1 64.3 ± 11.4 0.002*
Female gender 47 (22.2) 24 (37.5) 71 (25.7) 0.014
BMI (kg/m2) 27.8 (25.8–30.9) 26.6 (24.4–29.8) 27.8 (25.4–30.7) 0.026
NSTE-ACS subtype     0.733
 NSTEMI 175 (82.5) 54 (84.4) 229 (83.0)  
 UA 37 (17.5) 10 (15.6) 47 (17.0)  
Arterial hypertension 131 (61.8) 46 (71.9) 177 (64.1) 0.140
Diabetes mellitus 60 (28.3) 23 (35.9) 83 (30.1) 0.110
Hypercholesterolemia 106 (50.0) 32 (50.0) 138 (50.0) 0.999
Family history of CVD 76 (35.8) 25 (39.1) 101 (36.6) 0.640
Active smoking 62 (29.2) 14 (21.9) 76 (27.5) 0.260
Atrial fibrillation 15 (7.1) 11 (17.2) 26 (9.4) 0.015
Prior CAD 8 (3.8) 4 (6.3) 12 (4.3) 0.395
Prior MI 19 (9.0) 11 (17.2) 30 (10.9) 0.066
Prior PCI 17 (8.0) 6 (9.4) 23 (8.3) 0.731
PAD 20 (9.5) 9 (14.1) 29 (10.5) 0.432
COPD 26 (12.2) 7 (10.9) 33 (12.0) 0.920
Killip class > 1 20 (9.0) 8 (12.5) 28 (9.8) 0.692
Hgb (g/L) 143.0 (134.0–153.0) 137.0 (123.3–149.0) 141.2 (133.0–152.0) 0.010
Glucose (mmol/L) 7.1 (6.0–9.9) 7.4 (6.1–9.6) 7.1 (6.0–9.7) 0.672
CRP (mmol/L) 5.1 (2.0–10.5) 8.6 (1.5–29.3) 5.7 (1.7–12.9) 0.128
eGFR (ml/min) 91.8 ± 27.1 81.9 ± 28.3 89.5 ± 27.7 0.017*
LVEF (%) 59.0 (55.0–65.0) 55.0 (51.3–62.0) 58.0 (55.0–65.0) 0.046
Follow-up (months) 36.1 (29.5–43.8) 32.6 (26.5–43.5) 35.1 (29.3–44.0) 0.089
  1. Data are expressed as mean ± SD, number (percent) or median (interquartile range)
  2. BMI—body mass index; CAD—coronary arterial disease; COPD—chronic obstructive pulmonary disease; CRP—C-reactive peptide; CVD—cardiovascular disease; eGFR—estimated glomerular filtration rate; Hgb—hemoglobin; LVEF—left ventricular ejection fraction; MACE—major adverse cardiovascular events; MI—myocardial infarction; NSTE-ACS—non-ST elevation acute coronary syndrome; NSTEMI—non ST segment elevation myocardial infarction; UA—unstable angina; PAD—peripheral arterial disease; PCI—percutaneous coronary intervention
  3. *Student’s T test; Chi-square test; Mann–Whitney U test